Decline in Febuxostat Use Trends With Cardiovascular Concerns Decline in Febuxostat Use Trends With Cardiovascular Concerns
Allopurinol remains the first-line treatment, but it is not effective in all patients, and febuxostat was developed as an alternative.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Rheumatology News Source Type: news